GGrantIndex
Sort

326,823 grants matching clinical trial

The Immunobiology of Marrow Allografts for Leukemia

$3,117,289
Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA

Brain Tumor Clinical and Clinical Research Program

$3,116,819
Howard Fine · Division Of Basic Sciences - Nci · ZID · FY2010 · CA

Molecular Genetics of Vascular Disease

$3,116,778
Elizabeth G Nabel · National Human Genome Research Institute · Z01 · FY2008 · HG

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

$3,116,742
Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)

$3,116,337
Douglas Allen Corley · Kaiser Foundation Research Institute · UM1 · FY2019 · CA

Shared Resource Management

$3,115,740
M. Celeste Simon · University Of Pennsylvania · P30 · FY2024 · CA

Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease

$3,115,604
Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · AG

Radiobiology Research Suite Expansion of the TriMetis GLP Vivarium at UTHSC

$3,115,346
Gabor J Tigyi · University Of Tennessee Health Sci Ctr · C06 · FY2021 · OD

Pediatric Cancer Data Commons Harmonization

$3,115,327
National Cancer Institute · Y01 · FY2025 · CA

Clinical Trial of Ceftriaxone in ALS

$3,113,499
Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2006 · NS

Alzheimer's Disease Research Center

$3,113,485
Scott A Small · Columbia University Health Sciences · P30 · FY2022 · AG

Influenza and Emerging Infectious Diseases

$3,113,196
Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Immunobiology of Peanut Allergy and Its Treatment: A Prototype

$3,112,428
Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2009 · AI

Case Clinical Trials Unit

$3,112,121
Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2020 · AI

Novel Therapeutic Approaches to Increase Progranulin Levels in Brain to Treat FTD and AD

$3,112,016
Steven M Finkbeiner · J. David Gladstone Institutes · RF1 · FY2019 · AG

Centers for Innovative Research to Control AIDS

$3,111,555
Wafaa M. El-Sadr · Columbia University Health Sciences · U01 · FY2009 · AI

Next-Generation CMA/CMB Derivatives as Targeted Inhibitors of HIV Nef

$3,110,884
Kathleen L Collins · University Of Michigan At Ann Arbor · R01 · FY2025 · AI

Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB

$3,109,945
Carole D Mitnick · Harvard Medical School · U01 · FY2011 · AI

SPORE in Lymphoma

$3,109,934
Helen E Heslop · Baylor College Of Medicine · P50 · FY2025 · CA

Molecular Targets of Germinal Center B Cell Lymphomas

$3,109,897
Dana-Farber Cancer Institute · P01 · FY2003 · CA

Hippocampal iPSC-Derived Assembloids to Model Interneuron and Circuit Vulnerability in Genetically-Encoded Amnestic and Behavioral Dementia

$3,109,857
Jessica E Rexach · University Of California Los Angeles · RF1 · FY2025 · NS

APPLES: Apnea Positive Pressure Long-Term Efficacy Study

$3,109,570
Stanford University · U01 · FY2004 · HL

Influenza and Emerging Infectious Diseases

$3,109,509
Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

System Biological Analyses of Innate and Adaptive Responses to Vaccination

$3,109,475
Bali Pulendran · Emory University · U19 · FY2015 · AI

Biodefense and Emerging Infectious Disease Vaccine Studies

$3,109,113
Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI